The jury is still out, according to an analysis conducted by Cedars-Sinai.
The agency found several violations during an inspection related to its investigation of inaccurate blood lead test results.
The Class I recall is a result of a mold overflow defect that could obstruct blood flow.
Will the return of the 2.3% excise tax change how medtech companies do business?
3M to debut new adhesive product selection tool at CES 2018.
Economic development in China has created a burgeoning middle class that demands higher standards of living.
The program intends to promote quality in medical device design and manufacturing.
While Western countries still have more medical device startups than the rest of the world, more new medtech startups are popping up in Asia than ever before.
Priorities include unique device identification and next-generation sequencing for in vitro diagnostics.
New virtual and in-person workshops will bring together FDA and industry experts and stakeholders on a variety of key issues.